Charlene W Lai1, Terri H Lipman1,2, Steven M Willi1,3, Colin P Hawkes4,3. 1. Division of Endocrinology and Diabetes, Children's Hospital of Philadelphia, Philadelphia, PA. 2. School of Nursing, University of Pennsylvania, Philadelphia, PA. 3. Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. 4. Division of Endocrinology and Diabetes, Children's Hospital of Philadelphia, Philadelphia, PA hawkesc@email.chop.edu.
Abstract
OBJECTIVE: Racial/ethnic disparities in continuous glucose monitor (CGM) use exist among children with type 1 diabetes. It is not known whether differential rates of device initiation or sustained use are the cause of this disparity. Our objective was to compare CGM initiation rates and continued use among non-Hispanic White (NHW), non-Hispanic Black (NHB), and Hispanic children. RESEARCH DESIGN AND METHODS: We conducted a retrospective review including children with type 1 diabetes attending the Children's Hospital of Philadelphia between 1 January 15 and 31 December 18. RESULTS: Of 1,509 eligible children, 726 (48%) started CGM during the study period. More NHW (54%) than NHB (31%) and Hispanic (33%) children started CGM (P < 0.001). One year after starting, fewer NHB (61%) than NHW (86%) and Hispanic (85%) children were using CGM (P < 0.001). CONCLUSIONS: Lower CGM use in NHB children was due to lower rates of device initiation and higher rates of discontinuation. Interventions to address both of these barriers are needed to reduce disparities in CGM use.
OBJECTIVE: Racial/ethnic disparities in continuous glucose monitor (CGM) use exist among children with type 1 diabetes. It is not known whether differential rates of device initiation or sustained use are the cause of this disparity. Our objective was to compare CGM initiation rates and continued use among non-Hispanic White (NHW), non-Hispanic Black (NHB), and Hispanic children. RESEARCH DESIGN AND METHODS: We conducted a retrospective review including children with type 1 diabetes attending the Children's Hospital of Philadelphia between 1 January 15 and 31 December 18. RESULTS: Of 1,509 eligible children, 726 (48%) started CGM during the study period. More NHW (54%) than NHB (31%) and Hispanic (33%) children started CGM (P < 0.001). One year after starting, fewer NHB (61%) than NHW (86%) and Hispanic (85%) children were using CGM (P < 0.001). CONCLUSIONS: Lower CGM use in NHB children was due to lower rates of device initiation and higher rates of discontinuation. Interventions to address both of these barriers are needed to reduce disparities in CGM use.
Authors: Michelle L Litchman; Ashley Ng; Ana Sanchez-Birkhead; Nancy A Allen; Bruno Rodriguez-Gonzales; Eli Iacob; Deborah A Greenwood Journal: J Diabetes Sci Technol Date: 2021-08-20
Authors: Stephanie R Johnson; Deborah J Holmes-Walker; Melissa Chee; Arul Earnest; Timothy W Jones; Maria Craig; Kym Anderson; Geoff Ambler; Helen Barrett; Jenny Batch; Philip Bergman; Fergus Cameron; Peter Colman; Louise Conwell; Chris Cooper; Jennifer Couper; Elizabeth Davis; Martin de Bock; Kim Donaghue; Jan Fairchild; Gerry Fegan; Spiros Fourlanos; Sarah Glastras; Leonie Gray; Shane Hamblin; Paul Hofman; Dianne Jane Holmes-Walker; Neville Howard; Michelle Jack; Steven James; Craig Jefferies; Stephanie Johnson; Jeff Kao; Bruce R King; Antony Lafferty; Michelle Martin; Robert McCrossin; Mark Pascoe; Ryan Paul; Dorota Pawlak; Alexia Peña; Sarah Price; Darrell Price; Christine Rodda; David Simmons; Richard Sinnott; Alan Sive; Carmel Smart; Monique Stone; Steve Stranks; Elaine Tham; Charles Verge; Glenn Ward; Ben Wheeler; Judy Williams; Helen Woodhead; Nick Woolfield; Anthony Zimmermann Journal: Diabetes Care Date: 2022-02-01 Impact factor: 19.112
Authors: Persis V Commissariat; Lindsay C Roethke; Jennifer L Finnegan; Zijing Guo; Lisa K Volkening; Deborah A Butler; Eyal Dassau; Stuart A Weinzimer; Lori M Laffel Journal: Pediatr Diabetes Date: 2021-08-09 Impact factor: 4.866
Authors: Marie Auzanneau; Joachim Rosenbauer; Werner Maier; Simone von Sengbusch; Johannes Hamann; Thomas Kapellen; Guido Freckmann; Silke Schmidt; Eggert Lilienthal; Reinhard W Holl Journal: J Diabetes Sci Technol Date: 2021-07-12